United States · FDA National Drug Code directory
Regranex Gel 0.01%
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85822-734_a76b93e5-1b94-4a52-8efc-52c09c797ed6
- Product NDC
- 85822-734
- Form
- GEL
- Composition / generic term
- Becaplermin gel 0.01%
- Labeler
- LRM Therapeutics, LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 20250613
- Source listing expiry
- 20271231
Source-listed ingredients
- BECAPLERMIN — .1 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 15 g in 1 TUBE (85822-734-15) · 85822-734-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →